2-arachidonoylglycerol

2-arachidonoylglycerol is a lipid of Glycerolipids (GL) class. 2-arachidonoylglycerol is associated with abnormalities such as Atherosclerosis, Heart Diseases, Inflammatory disorder, Colitis and Peripheral Neuropathy. The involved functions are known as Immunoreactivity, inhibitors, Stimulus, Esthesia and Signal Transduction. 2-arachidonoylglycerol often locates in Back, Presynaptic Terminals, Brain region, Blood and Body tissue. The associated genes with 2-arachidonoylglycerol are ADRBK1 gene, Homologous Gene, MGLL gene, PLA2G4A gene and peptide V. The related lipids are oleoylethanolamide, Lipopolysaccharides, Promega, stearic acid and 1-stearoyl-2-arachidonoylglycerol. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of 2-arachidonoylglycerol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2-arachidonoylglycerol?

2-arachidonoylglycerol is suspected in Atherosclerosis, Heart Diseases, Sweet's Syndrome, Colitis, Dehydration, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2-arachidonoylglycerol

MeSH term MeSH ID Detail
Stomach Ulcer D013276 75 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Pain D010146 64 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hypotension D007022 41 associated lipids
Per page 10 20 50 100 | Total 51

PubChem Associated disorders and diseases

What pathways are associated with 2-arachidonoylglycerol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2-arachidonoylglycerol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2-arachidonoylglycerol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2-arachidonoylglycerol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 2-arachidonoylglycerol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 2-arachidonoylglycerol?

Knock-out

Knock-out are used in the study 'Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.' (Walentiny DM et al., 2015), Knock-out are used in the study 'Biochemical and pharmacological characterization of human α/β-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12).' (Navia-Paldanius D et al., 2012) and Knock-out are used in the study 'Metabolic Interplay between Astrocytes and Neurons Regulates Endocannabinoid Action.' (Viader A et al., 2015).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with 2-arachidonoylglycerol

Download all related citations
Per page 10 20 50 100 | Total 1060
Authors Title Published Journal PubMed Link
Fernández-Ochoa Á et al. Urinary and plasma metabolite differences detected by HPLC-ESI-QTOF-MS in systemic sclerosis patients. 2019 J Pharm Biomed Anal pmid:30227356
Biernacki M et al. Hypertension and chronic inhibition of endocannabinoid degradation modify the endocannabinoid system and redox balance in rat heart and plasma. 2018 Prostaglandins Other Lipid Mediat. pmid:30201316
DeVuono MV et al. Conditioned gaping produced by high dose Δ-tetrahydracannabinol: Dysregulation of the hypothalamic endocannabinoid system. 2018 Neuropharmacology pmid:30195587
Covey DP et al. Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington's disease. 2018 Neuropsychopharmacology pmid:29925886
Ratano P et al. Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation. 2018 Neuropharmacology pmid:29842858
Jehle J et al. Elevated levels of 2-arachidonoylglycerol promote atherogenesis in ApoE-/- mice. 2018 PLoS ONE pmid:29813086
Forner-Piquer I et al. Disruption of the gonadal endocannabinoid system in zebrafish exposed to diisononyl phthalate. 2018 Environ. Pollut. pmid:29793103
Baggelaar MP et al. 2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain. 2018 Prog. Lipid Res. pmid:29751000
Coccaro EF et al. Circulating endocannabinoids and affect regulation in human subjects. 2018 Psychoneuroendocrinology pmid:29627714
Nagappan A et al. Protective Effects of Gomisin N against Hepatic Cannabinoid Type 1 Receptor-Induced Insulin Resistance and Gluconeogenesis. 2018 Int J Mol Sci pmid:29570673
Wang Y et al. Identification of metabolite biomarkers for L-DOPA-induced dyskinesia in a rat model of Parkinson's disease by metabolomic technology. 2018 Behav. Brain Res. pmid:29551735
Wu SY et al. Metabolomic assessment of arsenite toxicity and novel biomarker discovery in early development of zebrafish embryos. 2018 Toxicol. Lett. pmid:29551592
Wingenfeld K et al. Reduced levels of the endocannabinoid arachidonylethanolamide (AEA) in hair in patients with borderline personality disorder - a pilot study. 2018 Stress pmid:29546791
Haj-Dahmane S et al. Fatty-acid-binding protein 5 controls retrograde endocannabinoid signaling at central glutamate synapses. 2018 Proc. Natl. Acad. Sci. U.S.A. pmid:29531087
Atsak P et al. Glucocorticoid-endocannabinoid uncoupling mediates fear suppression deficits after early - Life stress. 2018 Psychoneuroendocrinology pmid:29524763
Zareie P et al. Anticonvulsive effects of endocannabinoids; an investigation to determine the role of regulatory components of endocannabinoid metabolism in the Pentylenetetrazol induced tonic- clonic seizures. 2018 Metab Brain Dis pmid:29504066
Kamimura R et al. Inhibition of 2-arachydonoylgycerol degradation attenuates orofacial neuropathic pain in trigeminal nerve-injured mice. 2018 J Oral Sci pmid:29503395
Mecha M et al. 2-AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs. 2018 Glia pmid:29484707
Turunen PM et al. Endocannabinoid Signaling in Embryonic Neuronal Motility and Cell-Cell Contact - Role of mGluR5 and TRPC3 Channels. 2018 Neuroscience pmid:29438802
Shearer JA et al. Detrimental effects of 2-arachidonoylglycerol on whole blood platelet aggregation and on cerebral blood flow after a focal ischemic insult in rats. 2018 Am. J. Physiol. Heart Circ. Physiol. pmid:29351454
Heinitz S et al. Peripheral Endocannabinoids Associated With Energy Expenditure in Native Americans of Southwestern Heritage. 2018 J. Clin. Endocrinol. Metab. pmid:29300902
Morena M et al. Enhancing Endocannabinoid Neurotransmission Augments The Efficacy of Extinction Training and Ameliorates Traumatic Stress-Induced Behavioral Alterations in Rats. 2018 Neuropsychopharmacology pmid:29265107
Eroli F et al. Differential neuromodulatory role of endocannabinoids in the rodent trigeminal sensory ganglion and cerebral cortex relevant to pain processing. 2018 Neuropharmacology pmid:29225040
Sepers MD et al. Endocannabinoid-Specific Impairment in Synaptic Plasticity in Striatum of Huntington's Disease Mouse Model. 2018 J. Neurosci. pmid:29192125
Signorello MG and Leoncini G Activation of CaMKKβ/AMPKα pathway by 2-AG in human platelets. 2018 J. Cell. Biochem. pmid:28661046
Deng H and van der Stelt M Chemical tools to modulate 2-arachidonoylglycerol biosynthesis. 2018 Biotechnol. Appl. Biochem. pmid:28589628
Köse S et al. Human bone marrow mesenchymal stem cells secrete endocannabinoids that stimulate in vitro hematopoietic stem cell migration effectively comparable to beta-adrenergic stimulation. 2018 Exp. Hematol. pmid:29030083
Szafran BN et al. Characterization of Endocannabinoid-Metabolizing Enzymes in Human Peripheral Blood Mononuclear Cells under Inflammatory Conditions. 2018 Molecules pmid:30513753
Iannotti FA et al. Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy. 2018 Nat Commun pmid:30262909
Pasquarelli N et al. Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS. 2017 Neuropharmacology pmid:28373073
Bluett RJ et al. Endocannabinoid signalling modulates susceptibility to traumatic stress exposure. 2017 Nat Commun pmid:28348378
Kranaster L et al. Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study. 2017 Eur Arch Psychiatry Clin Neurosci pmid:28342110
Dotsey E et al. Transient Cannabinoid Receptor 2 Blockade during Immunization Heightens Intensity and Breadth of Antigen-specific Antibody Responses in Young and Aged mice. 2017 Sci Rep pmid:28209996
Avraham Y et al. 2-Arachidonoylglycerol as a possible treatment for anorexia nervosa in animal model in mice. 2017 Brain Res. pmid:28606779
Martin GG et al. Endocannabinoid Interaction with Human FABP1: Impact of the T94A Variant. 2017 Biochemistry pmid:28853554
Karwad MA et al. The role of CB in intestinal permeability and inflammation. 2017 FASEB J. pmid:28404744
Cui N et al. Restored Plasma Anandamide and Endometrial Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome by the Combination Use of Diane-35 and Metformin. 2017 Clin Ther pmid:28291580
Argueta DA and DiPatrizio NV Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity. 2017 Physiol. Behav. pmid:28065722
Gantz SC and Bean BP Cell-Autonomous Excitation of Midbrain Dopamine Neurons by Endocannabinoid-Dependent Lipid Signaling. 2017 Neuron pmid:28262417
Tanaka M et al. WWL70 attenuates PGE2 production derived from 2-arachidonoylglycerol in microglia by ABHD6-independent mechanism. 2017 J Neuroinflammation pmid:28086912
Feliú A et al. 2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination. 2017 J. Neurosci. pmid:28751457
Abed SM et al. Synthesis of 1,3-dioleoyl-2-arachidonoylglycerol-rich structured lipids by lipase-catalyzed acidolysis of microbial oil from Mortierella alpina. 2017 Bioresour. Technol. pmid:28688328
Karpińska O et al. Activation of CB receptors by 2-arachidonoylglycerol attenuates vasoconstriction induced by U46619 and angiotensin II in human and rat pulmonary arteries. 2017 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:28356298
Chanda D et al. 2-Arachidonoylglycerol ameliorates inflammatory stress-induced insulin resistance in cardiomyocytes. 2017 J. Biol. Chem. pmid:28320859
Bakas T et al. The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA receptors. 2017 Pharmacol. Res. pmid:28249817
Haruna T et al. The Inhibitory Effect of S-777469, a Cannabinoid Type 2 Receptor Agonist, on Skin Inflammation in Mice. 2017 Pharmacology pmid:28214870
Pagano E et al. Pharmacological inhibition of MAGL attenuates experimental colon carcinogenesis. 2017 Pharmacol. Res. pmid:28193521
Li B et al. Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur dioxide inhalation via cannabinoid receptors in the brain. 2017 J Environ Sci (China) pmid:28115138
Smaga I et al. Changes in the Brain Endocannabinoid System in Rat Models of Depression. 2017 Neurotox Res pmid:28247204
Quartu M et al. Involvement of the endocannabinoid system in the physiological response to transient common carotid artery occlusion and reperfusion. 2017 Lipids Health Dis pmid:28103941